Home
/ IMMY
/ Competitors

IMMY Competitors and Similar CompaniesClear all

IMMY's competitors and similar companies include Ceterix Orthopaedics, Evergen, Seegene and OrthoPediatrics.

	IMMY IMMY is a biotech company that manufactures, markets, and distributes its own lines of diagnostic tests and reagents.	Ceterix Orthopaedics Ceterix Orthopaedics develops novel surgical tools for arthroscopic procedures.	Evergen Evergen (formerly known as RTI Surgical) is a global surgical implant company providing surgeons with safe biologic, metal and synthetic implants.	Seegene Seegene ((주)씨젠) is a company that manufactures molecular diagnostics products.	OrthoPediatrics OrthoPediatrics designs, develops, manufactures, and distributes orthopedic implants and instruments for pediatric orthopedic surgeons.
Founding Date	Founding Date 1979	Founding Date 2010	Founding Date 1998	Founding Date 2000	Founding Date 2006
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech distribution healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices
Locations	Locations Norman, US HQ	Locations Fremont, US HQ	Locations Alachua, US HQ Metz, FR Neunkirchen Am Brand, DE Houten, NL Singapore, SG Greenville, US Marquette, US see more	Locations Seoul, KR HQ Contagem, BR Toronto, CA Düsseldorf, DE Genova, IT Ciudad De México, MX Dubai, AE see more	Locations Warsaw, US HQ
Employees	Employees 1091% decrease	Employees 2262% increase	Employees 8915% decrease	Employees 88478% increase	Employees 9418% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $280.9m (FY, 2018)	Revenue (est.) ₩474.2b (FY, 2025)	Revenue (est.) $236.3m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $140.7m (FY, 2018)	Cost of goods ₩133.4b (FY, 2025)	Cost of goods $63.7m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $140.1m (FY, 2018)	Gross profit ₩345b (FY, 2025)	Gross profit $172.7m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income ($1.3m) (FY, 2018)	Net income ₩48.4b (FY, 2025)	Net income ($39.6m) (FY, 2025)
Operating ⚠
Countries	Countries N/A	Countries N/A	Countries 45 (FY, 2016)	Countries 48 (Q2, 2020)	Countries 36 (Nov, 2017)
Distributors	Distributors N/A	Distributors N/A	Distributors N/A	Distributors 100 (Q3, 2022)	Distributors 31 (Nov, 2017)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 53m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 39m